Table 1 Demographic, neurological, and functional characteristics of the treatment and control groups at pre-test
|  | EDNA treatment (n = 10) | GRASP control (n = 7) | Comparison test |
|---|---|---|---|
Age (years)a | 69.9 (13.8), 49–90 | 77.3 (8.9), 60–85 | t = 1.241, p = 0.234 |
Genderb |  |  | χ2 = 0.004, p = 0.949 |
 Male | 7 | 5 |  |
 Female | 3 | 2 |  |
Rehab NIHSSa | 6.7 (3.0) | 7.8 (5.0) | t = 0.494, p = 0.631 |
Admission FIM scorea | 45.9 (24.8) | 40.6 (18.7) | t = 0.480, p = 0.638 |
Abilhand | 21.1 (10.5) | 36.4 (10.4) | t = 2.472, p = 0.051 |
FSS Total | 38.7 (13.5) | 30.3 (2.2) | t = 1.212, p = 0.249 |
Time since stroke (days)a | 137.5 (152.4) | 107.4 (56.4) | t = 0.496, p = 0.627 |
Stroke typeb |  |  | χ2 = 0.977, p = 0.323 |
 Ischemic strokeb | 9 (90%) | 5 (71%) |  |
 Hemorrhagic strokeb | 1 | 2 |  |
Side of lesion: left vs. right | 6 left: 4 right | 5 left: 2 right | χ2 = 0.235, p = 0.627 |
BBT, MAHa | 23.5 (9.6) | 15.7 (10.8) | t = 1.568, p = 0.138 |
BBT, LAHa | 41.2 (14.4) | 36.6 (10.8) | t = 0.720, p = 0.482 |
9HPT, MAHa | 0.21 (0.20) | 0.08 (0.14) | t = 1.462, p = 0.164 |
9HPT, LAHa | 0.58 (0.27) | 0.48 (0.15) | t = 0.857, p = 0.405 |
MoCAa | 18.5 (5.1) | 17.0 (7.8) | t = 0.491, p = 0.630 |
SIS Recovery Rating | 55.5 (16.4) | 45.0 (20.7) | t = 1.125, p = 0.279 |
NFI Totalc | 155.6 (38.1) | Â | Â |